Health
I-Mab Announces Appointments of Richard Yeh as Chief Operating Officer and John Hayslip as Chief Medical Officer
- Biotech and Wall Street veteran Mr. Richard Yeh to focus on strategic investor interactions, global alliance management and facilities as COO - Renowned oncology expert Dr. John Hayslip to further accelerate global clinical development of I-Mab's innovative pipeline as CMO SHANGHAI and GAITHE...
Gracell Biotechnologies Announces Details of Oral Abstract Presentation at 2022 ASCO Annual Meeting
Gracell to present longer-term follow-up clinical data evaluating GC012F, an autologous CAR-T therapeutic candidate dual-targeting BCMA and CD19, for the treatment of relapsed/refractory multiple myeloma SAN DIEGO, Calif. and SUZHOU, China, April 28, 2022 /PRNewswire/ -- Gracell Biotechnologies ...
ReviR Therapeutics Announces Dr. David Dornan as Independent Board Director
SOUTH SAN FRANCISCO, Calif., April 28, 2022 /PRNewswire/ -- ReviR Therapeutics, a biotechnology company focused on developing RNA-targeting small molecule drugs, announced today the appointment of Dr.David Dornan as an independent director. "We are thrilled to welcome David to our board of direc...
Lunit to Present 11 Abstracts at the 2022 ASCO Annual Meeting
* 7 poster presentations and 4 online publications, including research on AI biomarkers, have been accepted by ASCO * Findings demonstrate the practical effectiveness of Lunit's AI solution in the pathological assessment of cancer SEOUL, South Korea, April 28, 2022 /PRNewswire/ -- Lunit today...
Formosa Pharmaceuticals and AimMax Therapeutics to Present Phase 2 Trials Results of APP13007 for the Treatment after Cataract Surgery at ARVO 2022 Annual Meeting
TAIPEI, April 28, 2022 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (TWO.6838
HanAll Biopharma Reports First Quarter 2022 Results and Provides Business Update
* HanAll will expand R&D investments to advance its late-stage pipeline assets SEOUL, South Korea, April 28, 2022 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS), a global biopharma company committed to deliver innovative and impactful therapeutics to address severe unmet medical needs, tod...
WuXi Biologics' 2021 ESG Report Reveals Company's Strong Commitment to Overall Sustainability
- WuXi Biologics has aligned its ESG strategy with the United Nations Sustainable Development Goals (SDGs), as well as with its stakeholders' interests in sustainable business performance. - One example of WuXi Biologics' contribution to society is its rapid, robust pandemic response -- enab...
ASCO 2022 | Ascentage Pharma to Present Data from Seven Clinical Studies at the 2022 American Society of Clinical Oncology Annual Meeting
SUZHOU, China, and ROCKVILLE, MD, April 27, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that updated results from seven studies involving...
AIG Announces Widespread Growth in Q1 2022
Results Reflect Growing Demand for High-Quality Live Social Platforms NEW YORK, April 27, 2022 /PRNewswire/ -- Asia Innovations Group (AIG) today announced phenomenal growth in the first quarter of 2022. This growth spans across products, but is especially pronounced in AIG's live social platform...
China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement
HANGZHOU, China, April 27, 2022 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it ...
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in the United Kingdom
MELBOURNE, Australia, April 27, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that the United Kingdom Medicines & Healt...
Samsung Biologics Reports First Quarter 2022 Financial Results
* Q1'22 revenue of KRW 511.3 billion increased 96% compared to Q1'21. * Q1'22 operating profit of KRW 176.4 billion increased 137% compared to Q1'21. * Stable business operations and utilization rates across Plants 1, 2, and 3. * Proactive investments into long-term growth, capacity, and su...
RVAC Medicines, a CBC-Incubated mRNA Platform Company, Raises US$140 Million to Expand R&D and Manufacturing Capacity
Series B financing led by CBC with participation from Temasek's Pavilion Capital, EDBI and GS Holdings RVAC plans to build R&D center and manufacturing facilities in Singapore and China SINGAPORE, April 26, 2022 /PRNewswire/ -- RVAC Medicines Pte. Ltd. ("RVAC"), an emerging messenger RNA (mRNA)...
PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study
DAEJEON, South Korea, April 26, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today the positive results from the GLP toxicology study of PMC-403, the Company's novel TIE2-...
PharmAbcine Strengthens Scientific Advisory Board with a World-Renowned Expert in Ophthalmology
DAEJEON, South Korea, April 26, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today the appointment ofQuan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS to its Scientific Adviso...
Ubie, Japanese HealthTech Startup, Launches AI-powered Symptom Checker in U.S.
- Trusted by 4.5 Million Monthly Users Worldwide -
TOKYO and SINGAPORE, April 26, 2022 /PRNewswire/ -- Ubie, Inc., a healthcare
AI startup with the mission "To develop a healthcare guide for everyone," has
launched inthe United States an "AI-powered symptom checker" (
https://ubiehealth.com
DetectedX and GE Healthcare Enter Mammography Education Partnership to Improve Accuracy and Better Inform Clinical Decisions
Radiology Online Learning Centre from DetectedX – Available as Part of the GE Healthcare Clinical Education Program – Has Shown a 34% Improvement in the Accuracy of Diagnosing Difficult Cases SYDNEY, April 25, 2022 /PRNewswire/ -- Fostering global excellence in diagnostic accuracy, DetectedX and...
Volition Launches its Nu.Q® Vet Cancer Test in Asia Through its Appointed Distributor SAGE Healthcare
AUSTIN, Texas, April 25, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose and monitor a range of cancers and other life-altering diseases in both humans and ...
ITRI Named a Double Winner at Edison Awards 2022
HSINCHU, April 25, 2022 /PRNewswire/ -- The Edison Awards
WuXi AppTec Reports Record First-Quarter In 2022
Revenue Up 71.2% Year-Over-Year to RMB8,474 Million Net Profit Attributable to Owners of the Company Up 9.5% Year-Over-Year to RMB1,643 Million Diluted Earnings Per Share (EPS) Up 3.9% Year-Over-Year to RMB0.53 Adjusted Non-IFRS[1] Net Profit Attributable to Owners of the Company Up 85.8% Ye...
Week's Top Stories
Most Reposted
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
[Picked up by 319 media titles]
2024-11-07 09:00Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 311 media titles]
2024-11-12 09:00Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 288 media titles]
2024-11-13 09:00Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 286 media titles]
2024-11-12 11:00